Nathalie Jacque

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.

CAR T-cell therapy induces a high rate of prolonged remission in relapsed primary CNS lymphoma: Real-life results of the LOC network.

Journal: American journal of hematology
Published: November 27, 2023

Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.

Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.

Journal: Journal of hematology & oncology
Published: October 03, 2023

Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiation.

Inflammation in Waldenström macroglobulinemia is associated with 6q deletion and need for treatment initiation.

Journal: Haematologica
Published: March 25, 2022

CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC network.

CAR T-cell therapy in primary central nervous system lymphoma: the clinical experience of the French LOC network.

Journal: Blood
Published: June 11, 2021

Chronic lymphocytic leukemia

Chronic lymphocytic leukemia

Journal: Presse medicale (Paris, France : 1983)
Published: August 27, 2019

RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia.

RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia.

Journal: Leukemia
Published: May 10, 2017

Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia.

Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia.

Journal: Science advances
Published: February 23, 2015

Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.

Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition.

Journal: Blood
Published: January 14, 2015

Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia.

Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia.

Journal: Cell reports
Published: December 26, 2014

Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemia.

Chimerism analysis in peripheral blood using indel quantitative real-time PCR is a useful tool to predict post-transplant relapse in acute leukemia.

Journal: Bone marrow transplantation
Published: July 04, 2014

Targeting glutamine uptake in AML.

Targeting glutamine uptake in AML.

Journal: Oncoscience
Published: January 06, 2014

Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.

Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.

Journal: Blood
Published: September 10, 2013
Showing 1-12 of 14

Last Updated: 09/26/2026